+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Lewy Body Dementia Treatment Market by Treatment Modality (Non Pharmacological, Pharmacological), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End User, Route Of Administration, Treatment Line - Global Forecast 2025-2030- Product Image
Lewy Body Dementia Treatment Market by Treatment Modality (Non Pharmacological, Pharmacological), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End User, Route Of Administration, Treatment Line - Global Forecast 2025-2030- Product Image
Sale

Lewy Body Dementia Treatment Market by Treatment Modality (Non Pharmacological, Pharmacological), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End User, Route Of Administration, Treatment Line - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674515
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Lewy Body Dementia Treatment Market is experiencing considerable evolution, driven by increased R&D, rising disease awareness, and regulatory adaptations that are reshaping patient care and industry strategies. Senior healthcare and pharmaceutical leaders face a fast-changing landscape that requires agile decision-making, robust supply chain planning, and strategic alliances to stay ahead in this complex domain.

Market Snapshot: Lewy Body Dementia Treatment Market Dynamics

The Lewy Body Dementia Treatment Market grew from USD 6.60 billion in 2024 to USD 7.20 billion in 2025. It is expected to continue growing at a CAGR of 8.66%, reaching USD 10.88 billion by 2030. Market expansion is supported by ongoing research, emerging diagnostics, and the increasing complexity of care models. Strategic partnerships and a rising emphasis on both symptomatic management and disease-modifying therapies are playing a significant role in shaping the future of treatment standards.

Scope & Segmentation: Comprehensive Market Coverage

  • Treatment Modalities: Cognitive therapy, occupational therapy, physical therapy, speech therapy, cholinesterase inhibitors, dopaminergic agents, NMDA receptor antagonists.
  • Distribution Channels: Hospital pharmacies, online pharmacies, retail pharmacies.
  • End Users: Home care services, hospitals, specialty clinics.
  • Routes of Administration: Intravenous, oral, transdermal.
  • Treatment Lines: First line, second line, third line.
  • Geographic Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (such as United Kingdom, Germany, France, Russia, Italy, Spain, and additional countries), Asia-Pacific (including China, India, Japan, Australia, South Korea, and several others).
  • Key Companies: Eisai Co., Ltd., Biogen Inc., Novartis AG, Eli Lilly and Company, Pfizer Inc., Roche Holding AG, H. Lundbeck A/S, UCB Pharma S.A., ACADIA Pharmaceuticals Inc., Axovant Sciences Ltd.

Key Takeaways: Strategic Insights for Decision-Makers

  • Adopting digital health solutions and remote monitoring can improve clinical trial efficiency and enable personalized patient management across multiple care settings.
  • Strategic partnerships between pharmaceutical and biotechnology players are accelerating access to novel therapeutics and delivery technologies, including transdermal and intranasal systems.
  • Non-pharmacological interventions such as cognitive and occupational therapy remain critical alongside pharmacological advances and help maintain patient independence.
  • Supply chain management is increasingly complex, requiring diversification of sourcing and the development of local manufacturing capabilities to reduce operational risk.
  • Regional market differences in reimbursement policy, regulatory approval timelines, and healthcare infrastructure require localized go-to-market strategies and customized value propositions.
  • Investment in real-world data collection, particularly through digital biomarkers and patient advocacy networks, can optimize product positioning and bolster health technology assessment outcomes.

Tariff Impact: Navigating U.S. Trade Policy Shifts

New United States tariffs enacted in 2025 have affected global supply chains for Lewy Body Dementia treatments, increasing production costs and compelling manufacturers to identify alternative supply pathways. This has led to adjusted clinical trial planning, more frequent stockpiling, and a reliance on new regional partnerships to maintain product availability. Balancing these disruptions while ensuring regulatory compliance and quality standards remains pivotal for operational continuity.

Methodology & Data Sources

This report leverages a rigorous methodology, consisting of expert interviews with clinicians and trial investigators, comprehensive secondary reviews of medical literature and regulatory filings, and triangulation of quantitative data with publicly accessible databases. The approach provides both broad and deep insights into current and emerging market trends.

Why This Report Matters

  • Enables executives to anticipate market shifts and allocate resources effectively by identifying growth drivers and competitive risks in the Lewy Body Dementia Treatment Market.
  • Supports strategic planning by clarifying regional opportunities and illuminating key technology and partnership trends relevant to new entrants and established players alike.

Conclusion

Senior stakeholders will benefit from this report’s actionable intelligence, guiding investment, operational, and partnership decisions for future success in Lewy Body Dementia treatment. Organizations aligning innovation, regional adaptation, and operational resilience are best positioned to lead in this evolving market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advancements in alpha-synuclein targeted immunotherapies showing promising clinical trial efficacy
5.2. Integration of digital biomarkers and wearable technology to monitor cognitive and motor fluctuations
5.3. Emergence of combination therapy protocols addressing both cognitive decline and motor symptoms
5.4. Personalized treatment approaches based on genetic and biomarker stratification in LBD patients
5.5. Regulatory progress and accelerated approval pathways for novel Lewy body dementia therapeutics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Lewy Body Dementia Treatment Market, by Treatment Modality
8.1. Introduction
8.2. Non Pharmacological
8.2.1. Cognitive Therapy
8.2.2. Occupational Therapy
8.2.3. Physical Therapy
8.2.4. Speech Therapy
8.3. Pharmacological
8.3.1. Cholinesterase Inhibitors
8.3.1.1. Donepezil
8.3.1.2. Galantamine
8.3.1.3. Rivastigmine
8.3.2. Dopaminergic Agents
8.3.3. NMDA Receptor Antagonists
9. Lewy Body Dementia Treatment Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies
10. Lewy Body Dementia Treatment Market, by End User
10.1. Introduction
10.2. Home Care Services
10.3. Hospitals
10.4. Specialty Clinics
11. Lewy Body Dementia Treatment Market, by Route Of Administration
11.1. Introduction
11.2. Intravenous
11.3. Oral
11.4. Transdermal
12. Lewy Body Dementia Treatment Market, by Treatment Line
12.1. Introduction
12.2. First Line
12.3. Second Line
12.4. Third Line
13. Americas Lewy Body Dementia Treatment Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Lewy Body Dementia Treatment Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Lewy Body Dementia Treatment Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Eisai Co., Ltd.
16.3.2. Biogen Inc.
16.3.3. Novartis AG
16.3.4. Eli Lilly and Company
16.3.5. Pfizer Inc.
16.3.6. Roche Holding AG
16.3.7. H. Lundbeck A/S
16.3.8. UCB Pharma S.A.
16.3.9. ACADIA Pharmaceuticals Inc.
16.3.10. Axovant Sciences Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. LEWY BODY DEMENTIA TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. LEWY BODY DEMENTIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. LEWY BODY DEMENTIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. LEWY BODY DEMENTIA TREATMENT MARKET: RESEARCHAI
FIGURE 26. LEWY BODY DEMENTIA TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 27. LEWY BODY DEMENTIA TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 28. LEWY BODY DEMENTIA TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. LEWY BODY DEMENTIA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COGNITIVE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COGNITIVE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY OCCUPATIONAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY OCCUPATIONAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY SPEECH THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY SPEECH THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DONEPEZIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DONEPEZIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY GALANTAMINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY GALANTAMINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY RIVASTIGMINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY RIVASTIGMINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DOPAMINERGIC AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DOPAMINERGIC AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NMDA RECEPTOR ANTAGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NMDA RECEPTOR ANTAGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY HOME CARE SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY HOME CARE SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TRANSDERMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY FIRST LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY FIRST LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY SECOND LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY SECOND LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY THIRD LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY THIRD LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 109. CANADA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 110. CANADA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 111. CANADA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 112. CANADA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 113. CANADA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 114. CANADA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 115. CANADA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 116. CANADA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 117. CANADA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. CANADA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. CANADA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. CANADA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. CANADA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 122. CANADA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 123. CANADA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2018-2024 (USD MILLION)
TABLE 124. CANADA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2025-2030 (USD MILLION)
TABLE 125. MEXICO LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 126. MEXICO LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 127. MEXICO LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 128. MEXICO LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 129. MEXICO LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 130. MEXICO LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 131. MEXICO LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 132. MEXICO LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 133. MEXICO LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. MEXICO LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. MEXICO LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. MEXICO LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. MEXICO LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 138. MEXICO LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 139. MEXICO LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2018-2024 (USD MILLION)
TABLE 140. MEXICO LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2025-2030 (USD MILLION)
TABLE 207. GERMANY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 208. GERMANY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 209. GERMANY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 210. GERMANY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 211. GERMANY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 212. GERMANY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 213. GERMANY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 214. GERMANY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 215. GERMANY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. GERMANY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. GERMANY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. GERMANY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. GERMANY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 220. GERMANY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 221. GERMANY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2018-2024 (USD MILLION)
TABLE 222. GERMANY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2025-2030 (USD MILLION)
TABLE 223. FRANCE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 224. FRANCE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 225. FRANCE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 226. FRANCE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 227. FRANCE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 228. FRANCE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 229. FRANCE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 230. FRANCE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 231. FRANCE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. FRANCE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. FRANCE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. FRANCE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. FRANCE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 236. FRANCE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 237. FRANCE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2018-2024 (USD MILLION)
TABLE 238. FRANCE LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2025-2030 (USD MILLION)
TABLE 255. ITALY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 256. ITALY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 257. ITALY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 258. ITALY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 259. ITALY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 260. ITALY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 261. ITALY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 262. ITALY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 263. ITALY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. ITALY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. ITALY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. ITALY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. ITALY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 268. ITALY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 269. ITALY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2018-2024 (USD MILLION)
TABLE 270. ITALY LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2025-2030 (USD MILLION)
TABLE 271. SPAIN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 272. SPAIN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 273. SPAIN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 274. SPAIN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 275. SPAIN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 276. SPAIN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 277. SPAIN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 278. SPAIN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 279. SPAIN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. SPAIN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. SPAIN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. SPAIN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. SPAIN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 284. SPAIN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 285. SPAIN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2018-2024 (USD MILLION)
TABLE 286. SPAIN LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT LINE, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY TREATMENT MODALITY, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES LEWY BODY DEMENTIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES LEW

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Lewy Body Dementia Treatment market report include:
  • Eisai Co., Ltd.
  • Biogen Inc.
  • Novartis AG
  • Eli Lilly and Company
  • Pfizer Inc.
  • Roche Holding AG
  • H. Lundbeck A/S
  • UCB Pharma S.A.
  • ACADIA Pharmaceuticals Inc.
  • Axovant Sciences Ltd.

Table Information

Report AttributeDetails
No. of Pages199
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 7.2 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.88 Billion
Compound Annual Growth Rate8.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Lewy Body Dementia Treatment Market Report 2025 - Product Image

Lewy Body Dementia Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Lewy Body Dementia (LBD) - Pipeline Insight, 2025 - Product Image

Lewy Body Dementia (LBD) - Pipeline Insight, 2025

  • Drug Pipelines
  • 60 Pages
  • Global
From
Lewy Body Dementia Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Lewy Body Dementia Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 83 Pages
  • Global
From
Dementia Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Dementia Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 186 Pages
  • Global
From
Dementia Drugs - Global Strategic Business Report - Product Image

Dementia Drugs - Global Strategic Business Report

  • Report
  • 286 Pages
  • Global
From

About the Market

The Dementia Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Dementia drugs are used to treat the cognitive decline associated with Alzheimer's disease, vascular dementia, and other forms of dementia. These drugs are typically prescribed to improve memory, thinking, and behavior, as well as to slow the progression of the disease. Common dementia drugs include cholinesterase inhibitors, memantine, and glutamate modulators. Some companies in the Dementia Drug market include Pfizer, Novartis, Merck, and Eli Lilly. Other companies include Biogen, AstraZeneca, and Johnson & Johnson. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.